110 ALK-Rearranged Renal Cell Carcinoma Mimicking Metanephric Adenoma in a Young Woman
Abstract
ALK-rearranged renal cell carcinoma (ALK-RCC) is a rare malignancy that can diagnostically overlap with benign metanephric adenoma (MA). Distinguishing them is critical; ALK-RCC is a malignant tumor potentially responsive to targeted therapies, whereas MA is a benign lesion. In this case, a 32-year-old female underwent partial nephrectomy for a 2.3 cm left renal mass. Evaluation revealed a well-circumscribed lesion with over 95% of tumor cells mimicking a MA with basaloid renal tubules and glomerular structures. Unlike adult Wilms tumor, it lacked significant pleomorphism and a blastemal component. The basaloid cells were positive for WT1 and CD57 but negative for BRAF. Scattered foci displayed differentiated tubules with papillary architecture positive for CK7 and focally positive for AMACR. All tumor cells showed diffuse positivity for PAX8. Importantly, all tumor cells showed diffuse ALK immunoreactivity. Based on these findings, the diagnosis of ALK-RCC mimicking MA was rendered. NA Recognition of diffuse ALK expression is a key diagnostic clue in renal tumors with MA-like morphology and immunohistochemistry. Accurate identification is critical in cases of metastatic ALK-RCC, which may respond to ALK inhibitors such as crizotinib. Routine ALK immunohistochemistry should be considered in MA-like renal tumors to ensure accurate classification and optimal clinical management.